Patent Number: 
Section: claims

1. A method of producing medical isotopes using an apparatus having:a reactor chamber configured to control irradiation of material contained in the reaction chamber;a plurality of containers that are together removably insertable into the chamber, wherein each respective container comprises container walls, wherein the container walls define an enclosed container interior, wherein the container interior includes a volume holding a dry granular uranium compound, wherein the reaction chamber is configured to control irradiation of dry granular uranium compound held in a container inserted into the reaction chamber, to cause generation of an isotope, wherein each respective container includes a cooling channel that passes through the container interior while being inwardly spaced from the container walls, wherein the cooling channel comprises tubing, wherein the tubing is configured to receive cooling fluid, wherein the tubing is configured to allow received cooling fluid to flow therein through the container interior while the cooling fluid is both in thermal contact with the dry granular uranium compound, and physically isolated from the contained dry granular uranium compound; anda material processor having a separator operably configured to process the dry granular uranium compound by (a) dissolving the dry granular uranium in a solvent and then (b) separating the isotope from the granular uranium compound, the method comprising the steps of:(a) exposing a dry granular uranium compound to radiation to produce the medical isotope by nuclear reaction;(b) dissolving the irradiated uranium compound in a solvent; and(c) separating the medical isotope from the solventized uranium compound to provide an isolated medical isotope. 2. The method of claim 1 wherein the uranium compound is selected from the group consisting of uranium oxides and uranium salts. 3. The method of claim 1 wherein the uranium salt is selected from the group consisting of uranyl nitrite or uranyl sulfate. 4. The method of claim 1 further including the step of (d) reconstituting the dry granular uranium compound by removing the solvent and repeating steps (a)-(c). 5. The method of claim 1 wherein the solvent is an acid selected from the group consisting of nitric acid and sulfuric acid. 6. The method of claim 1 further including the step of cooling the dry granular uranium compound by a flow of fluid in thermal physical contact with the granular uranium compound during step (a). 7. The method of claim 1 wherein the medical isotope is 99Mo. 8. The method of claim 1 wherein in step (a) the dry granular uranium compound is held in multiple containers and wherein step (b) dissolves the irradiated uranium compound in the solvent in the containers and then removes the solvent from the containers along with the dissolved uranium compound. 9. The method of claim 1 further including placement of one or more reflectors reflecting radiation near the dry granular uranium compound during irradiation. 10. The method of claim 1 including the step of moving neutron absorbing control elements in a region near the dry granular uranium compound during irradiation to maintain critical reaction during step (a). 11. The method of claim 1 wherein the radiation is produced by an electrically powered neutron generator irradiating the dry granular uranium compound in a sub-critical reactor. 12. An apparatus for producing medical isotopes comprising:a reaction chamber configured to control irradiation of material contained in the reaction chamber;a plurality of containers that are together removably insertable into the reaction chamber,wherein each respective container comprises container walls,wherein the container walls define an enclosed container interior,wherein the container interior includes a volume holding a dry granular uranium compound,wherein the reaction chamber is configured to control irradiation of dry granular uranium compound held in a container inserted into the reaction chamber, to cause generation of an isotope,wherein each respective container includes a cooling channel that passes through the container interior while being inwardly spaced from the container walls,wherein the cooling channel comprises tubing,wherein the tubing is configured to receive cooling fluid,wherein the tubing is configured to allow received cooling fluid to flow therein through the container interior while the cooling fluid is bothin thermal contact with the dry granular uranium compound, andphysically isolated from the contained dry granular uranium compound; anda material processor having a separator operably configured to process the dry granular uranium compound by (a) dissolving the dry granular uranium in a solvent, and then (b) separating the isotope from the granular uranium compound. 13. The apparatus of claim 12 wherein each respective container includes a second channel comprising tubing wherein the tubing is configured to allow a received stream of water to pass into the container interior while the stream of water is in contact with the dry granular uranium compound to dissolve and flush the dry granular uranium compound from the container. 14. The apparatus of claim 12 wherein each respective container includes at least one barrier for distributing the dry, granular uranium compound into a geometrical configuration that does not support sustained nuclear reaction. 15. The apparatus of claim 12 further including one or more reflectors reflecting radiation near the dry granular uranium compound during irradiation. 16. The apparatus of claim 12 wherein the uranium compound is selected from a group consisting of uranium oxides and uranium salts. 17. The apparatus of claim 16 wherein the uranium salt is selected from the group consisting of uranyl nitrite or uranyl sulfate. 18. The apparatus of claim 12 wherein the solvent is an acid selected from a group consisting of nitric acid and sulfuric acid. 19. The apparatus of claim 12 wherein the containers are arranged in at least two concentric rings.